Home › Funds › Balyasny Asset Management › EDIT
Balyasny Asset Management position in EDIT
EDITAS MEDICINE INC · Health Care
Latest position (Q2 2026)37.64K sh
Reported value held$121.95K
Portfolio Weight0.00%
First reportedQ2 2022
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2022 | 314.25K | $3.72M | New |
| Q3 2022 | 110.20K | $1.35M | Reduce |
| Q4 2022 | 345.94K | $3.07M | Add |
| Q4 2023 | 59.32K | $600.94K | New |
| Q1 2024 | 292.71K | $2.17M | Add |
| Q2 2024 | 37.97K | $177.31K | Reduce |
| Q3 2024 | 174.03K | $593.46K | Add |
| Q4 2024 | 1.30M | $1.65M | Add |
| Q2 2026 | 37.64K | $121.95K | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding EDIT
- BlackRock Inc 10.59M sh · $34.31M · Q2 2026
- Vanguard Group 8.21M sh · $16.83M · Q4 2025
- Goldman Sachs Group 2.61M sh · $8.47M · Q2 2026
- Geode Capital Management 2.57M sh · $8.33M · Q2 2026
- Renaissance Technologies 2.47M sh · $8.00M · Q2 2026
- Marshall Wace 2.04M sh · $6.60M · Q2 2026
- D. E. Shaw & Co 1.90M sh · $6.16M · Q2 2026
- JPMorgan Chase & Co 1.86M sh · $5.96M · Q2 2026
- AQR Capital Management 1.57M sh · $5.09M · Q2 2026
- Two Sigma Investments 1.33M sh · $4.32M · Q2 2026
- Charles Schwab Investment Management 868.03K sh · $2.81M · Q2 2026
- Northern Trust Corp 819.69K sh · $2.66M · Q2 2026